Latest News and Press Releases

WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to...

aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS)New vaccine program is added to Evaxion’s...

MetasTx has been awarded a NCI SBIR grant for its integrated diagnostic and therapeutic platform aimed at predicting and preventing prostate cancer.

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Lab-on-a-Chip & Microfluidics Asia, Organoids & Organ-on-a-Chip Asia 2025 Conference" conference has been added to ResearchAndMarkets.com's...

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Lab-on-a-Chip and Microfluidics World Congress 2025" conference has been added to ResearchAndMarkets.com's offering. Welcome to the 18th Annual...

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "FDA Regulatory Compliance for Drug and Biotech Products (ONLINE EVENT: July 16-17, 2025)" training has been added to ResearchAndMarkets.com's...

Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a clinical programme evaluating mocravimod added to standard CAR-T cell...

Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports...

MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo (p<0.00001), with up to 48.1% of participants achieving ≥10% weight loss.No...